Australia Ends COVID-19 Vaccine Trials After Participants Test Positive For HIV Antibody


(TJVNEWS.COM) The backers of Australia’s homegrown COVID-19 vaccine candidate, earlier this week, announced a halt to its further development, after some of the first people to receive the vaccine in a safety trial generated antibodies to an unintended target, the AIDS virus.

A small fragment of an HIV protein is a component of the vaccine used to add stability to the intended antibody target, the spike protein of the pandemic coronavirus SARS-CoV-2,  Science Mag reported. Unfortunately, that HIV fragment also generated antibodies that could confuse diagnostic tests.

Researchers recognized the possibility that the HIV component might invoke an immune response. But, “It was unexpected that the levels induced would interfere with certain HIV tests,” reads a joint statement announcing the halt of the candidate’s development that was posted online by UQ and CSL- Science Mag reported.

There were no serious adverse events or safety concerns reported in the 216 participants of the phase 1 trial of the v451 COVID-19 vaccine candidate being developed by the University of Queensland (UQ) in collaboration with biotech company CSL, according to a statement.

The university said there is no possibility the vaccine causes infection, and routine follow-up tests confirmed there is no HIV virus present.

Interestingly enough, earlier in the year, at the height of the pandemic and COVID hysteria,  Professor Luc Montagnier, winner of the Nobel Prize for Medicine in 2008 for “discovering” HIV as the cause of the AIDS epidemic,  claimed on French media that COVID 19 was created in Wuhan lab, while scientists were experimenting on an HIV vaccination

TJV reported in April:

Professor Luc Montagnier claims the SARS-CoV-2 responsible for the Covid-19 pandemic is a virus that was manipulated and accidentally released from a laboratory in Wuhan, China, in the last quarter of 2019. According to Professor Montagnier, this laboratory, known for its work on coronaviruses, tried to use one of these viruses as a vector for HIV in the search for an AIDS vaccine,  Gilmore Health reported after Montagnier was interviewed on a medical podcast.